FDA enforcement records dated October 7, 2026 identify Alere San Diego, Inc. of San Diego, California as the recalling firm for four Class II recalls of hCG rapid pregnancy tests. All four records share event ID 99409, describe the action as voluntary and firm initiated, and list the recall status as ongoing. The stated reason across the records is that hCG rapid tests may detect low levels of hCG below the stated assay sensitivity, which may result in a false positive result. The records cover cassette, combo cassette, dipstick and strip formats distributed under several brand labels. [1][2][3][4]

Documented products and test formats

The recalled products span urine-only and serum-or-urine formats. One record covers the Alere hCG Combo Cassette (25 mIU/mL) in urine, CLIA waived, or serum, alongside Fisher Scientific Sure-Vue Serum/Urine hCG, Beckman Coulter ICON 25 hCG, Henry Schein One Step+ hCG Combo and Pro Advantage by NDC Urine/Serum Pregnancy Cassette Device. A second record covers the Alere hCG Cassette (25 mIU/mL) in urine with Fisher Scientific Sure-Vue Urine hCG, Henry Schein One Step+ Urine Cassette, Cardinal Health hCG Cassette Rapid Test, Medline HCG Pregnancy Test Cassette and Pro Advantage by NDC Urine Pregnancy Cassette Device. [1][2]

A third record covers the Alere hCG Dipstick (25 mIU/mL) in urine with Fisher Scientific Sure-Vue Urine hCG Strip, McKesson CONSULT hCG Urine Test Dipstick, Henry Schein One Step+ hCG Urine Strip, Cardinal Health hCG Dipstick Rapid Test, Medline hCG Pregnancy Test Strip and Pro Advantage by NDC Urine Pregnancy Test Strip. A fourth record covers the Alere hCG Cassette (20 mIU/mL) in urine and the Alere hCG Combo Cassette (20/10 mIU/mL) for urine or serum, with McKesson CONSULT hCG Urine Cassette, Fisher Scientific Sure-Vue Serum/Urine hCG-STAT, McKesson CONSULT Diagnostics hCG Urine Cassette, Cardinal Health hCG Combo Rapid Test and Medline hCG Combo Pregnancy Test Cassette. [3][4]

Recall scope and quantities

The four records list product quantities of 5,331,585 units, 18,139,960 units, 13,256,075 units and 50,265,835 units respectively. Each record states that all lots within the expiration date are affected and lists part numbers, UDI-DI values and labeling versions with dates. The records describe worldwide distribution, with US nationwide distribution including states such as Illinois, Pennsylvania, Florida, Georgia, Virginia, New York, Tennessee, Arizona, Idaho, North Dakota, Wisconsin, Alabama, Louisiana, New Jersey, Montana, Nebraska, Ohio, Puerto Rico, Indiana, Michigan, Wyoming, Massachusetts, California, Texas, Hawaii, Kansas, Kentucky, Arkansas, Colorado, North Carolina, Washington, Iowa, Minnesota, Oklahoma, Oregon, New Mexico, South Carolina, Guam, Maryland, Nevada, Mississippi, West Virginia, South Dakota, Vermont and Delaware, plus the United Kingdom, Canada, Italy, Ireland, Spain, Portugal, New Zealand, Hong Kong, Australia, Papua New Guinea, Fiji, Guam and Sweden. [1][2][3][4]

Filing dates and classification

The records give a recall initiation date of August 20, 2026 and a center classification date of September 25, 2026, with a report date of October 7, 2026. Each is classified Class II. FDA recall database pages separately list Class 2 device recalls titled hCG Pregnancy Test Device (Urine/Serum) and hCG Pregnancy Test Device (Urine). A third-party summary published by Recall Canary, posted September 25, 2026 and updated October 31, 2026, describes the action as moderate risk and states that Alere San Diego initiated the recall covering products sold under the McKesson, Alere, Fisher Scientific and Henry Schein labels. [3][4][5][6][10]

Labeling and catalog references

Fisher Scientific product pages list the Fisher Healthcare Sure-Vue Serum/Urine hCG Test Kit under catalog numbers 23900528 for 30 tests and 23900529 for 50 tests, matching part numbers named in the FDA records. The FDA records identify Alere San Diego, Inc. at 9942 Mesa Rim Rd, San Diego, CA 92121-2997 as the recalling firm; that filing address is not treated here as a verified headquarters. No parent, brand ownership, website or customer relationships are established by these records. [1][8][9]